P

Inventor

CHACKALAMANNIL SAMUEL

US77 patents
⚠️ This page may combine multiple inventors who share the name “CHACKALAMANNIL SAMUEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

40 patents
US6821978B2Nov 23, 2004

Xanthine phosphodiesterase V inhibitors

SCHERING CORP140 citations99
US6645987B2Nov 11, 2003

Nor-seco himbacine derivatives useful as thrombin receptor antagonists

SCHERING CORP97 citations98
US6063847AMay 16, 2000

Thrombin receptor antagonists

SCHERING CORP180 citations98
US5977138ANov 2, 1999

Ether muscarinic antagonists

SCHERING CORP99 citations98
US5883096AMar 16, 1999

Muscarinic antagonists

SCHERING CORP164 citations98
US6326380B1Dec 4, 2001

Thrombin receptor antagonists

SCHERING CORP103 citations97
US6037352AMar 14, 2000

Muscarinic antagonists

SCHERING CORP90 citations97
US5889006AMar 30, 1999

Muscarinic antagonists

SCHERING CORP123 citations97
US7304078B2Dec 4, 2007

Thrombin receptor antagonists

SCHERING CORP43 citations96
US6630475B2Oct 7, 2003

Adenosine A2a receptor antagonists

SCHERING CORP53 citations95
US6043255AMar 28, 2000

Muscarinic antagonists

SCHERING CORP50 citations95
US6969719B2Nov 29, 2005

Polycyclic guanine phosphodiesterase V inhibitors

SCHERING CORP59 citations94
US7776889B2Aug 17, 2010

Spirocyclic thrombin receptor antagonists

SCHERING CORP20 citations92
US7037920B2May 2, 2006

Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists

SCHERING CORP52 citations92
US6897217B2May 24, 2005

2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

SCHERING CORP25 citations92
US6894065B2May 17, 2005

Thrombin receptor antagonists

SCHERING CORP31 citations92
US5476847ADec 19, 1995

Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors

SCHERING CORP25 citations92
US6288068B1Sep 11, 2001

Muscarinic antagonists

SCHERING CORP22 citations91
US7662816B2Feb 16, 2010

Cyclic amine BACE-1 inhibitors having a benzamide substituent

SCHERING CORP11 citations84
US7713999B2May 11, 2010

Thrombin receptor antagonists

SCHERING CORP8 citations83
US6916811B2Jul 12, 2005

Adenosine A2a receptor antagonists

SCHERING CORP17 citations83
US6890936B2May 10, 2005

Muscarinic antagonists

SCHERING CORP9 citations74
US5506236AApr 9, 1996

4-substituted pyrazoloquinoline derivatives

SCHERING CORP7 citations74
US6897216B2May 24, 2005

Adenosine A2a receptor antagonists

SCHERING CORP5 citations73
US6498168B2Dec 24, 2002

Muscarinic antagonists

SCHERING CORP5 citations73
US7572802B2Aug 11, 2009

7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine

SCHERING CORP7 citations71
US8022088B2Sep 20, 2011

Substituted bicyclic and tricyclic thrombin receptor antagonists

SCHERING CORP5 citations63
US8003803B2Aug 23, 2011

Fused ring thrombin receptor antagonists

SCHERING CORP4 citations63
US7888369B2Feb 15, 2011

Oxazoloisoquinoline derivatives as thrombin receptor antagonists

SCHERING CORP4 citations63
US7531544B2May 12, 2009

Xanthine phosphodiesterase V inhibitors

SCHERING CORP2 citations63
US7488742B2Feb 10, 2009

Thrombin receptor antagonists

SCHERING CORP5 citations63
US5459146AOct 17, 1995

4-substituted pyrazoloquinoline derivatives

SCHERING CORP5 citations63
US4740595AApr 26, 1988

Preparation of azetidinones via N-protected oxirancecarboxamide intermediates

SCHERING CORP2 citations63
US7713985B2May 11, 2010

Adenosine Aa2 receptor antagonists

SCHERING CORP4 citations62
US7709492B2May 4, 2010

Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

SCHERING CORP2 citations62
US7465740B2Dec 16, 2008

2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

SCHERING CORP3 citations62
US7368449B2May 6, 2008

2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

SCHERING CORP4 citations62
US7488752B2Feb 10, 2009

Thrombin receptor antagonists

SCHERING CORP6 citations60
US7442712B2Oct 28, 2008

Constrained himbacine analogs as thrombin receptor antagonists

SCHERING CORP6 citations60
US7268141B2Sep 11, 2007

Xanthine phosphodiesterase V inhibitors

SCHERING CORP4 citations60

CUMMING JARED N

2 patents

MERCK SHARP & DOHME

2 patents

SCHERING PLOUGH CORP

1 patent

(unassigned)

1 patent

XIA YAN

1 patent

NEELAMKAVIL SANTHOSH FRANCIS

1 patent

PHARMACOPEIA DRUG DISCOVERY

1 patent

BOYLE CRAIG D

1 patent

Showing the top 50 of 77 patents by PatentIndex Score.